Redhill Biopharma (STU:2RH) FCF Margin %: 122.26% (As of Dec. 2025)


STU:2RH Redhill Biopharma Ltd STU:2RH
18 GF Score
Price €8.24
! 6 Warning Signs
View Full Analysis

What is Redhill Biopharma FCF Margin %?

Redhill Biopharma STU:2RH 18 FCF Margin % is 122.26% as of Dec. 2025. GuruFocus rates STU:2RH with a GF Score™ of 18/100. The stock has 6 warning signs investors should review. Among 958 Drug Manufacturers companies, Redhill Biopharma ranks worse than 98.43% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Redhill Biopharma's Free Cash Flow for the six months ended in Dec. 2025 was €-3.96 Mil. Redhill Biopharma's Revenue for the six months ended in Dec. 2025 was €-3.24 Mil. Therefore, Redhill Biopharma's FCF Margin % for the quarter that ended in Dec. 2025 was 122.26%.

As of today, Redhill Biopharma's current FCF Yield % is -209.19%.

The historical rank and industry rank for Redhill Biopharma's FCF Margin % or its related term are showing as below:

STU:2RH' s FCF Margin % Range Over the Past 10 Years
Min: -28097.03   Med: -531.94   Max: -47.55
Current: -2798.32

During the past 13 years, the highest FCF Margin % of Redhill Biopharma was -47.55%. The lowest was -28097.03%. And the median was -531.94%.

STU:2RH's FCF Margin % is ranked worse than
98.43% of 958 companies
in the Drug Manufacturers industry
Industry Median: 2.51 vs STU:2RH: -2798.32

Redhill Biopharma FCF Margin % Related Terms

Redhill Biopharma FCF Margin % Historical Data

* Premium members only.

The historical data trend for Redhill Biopharma's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Redhill Biopharma FCF Margin % Chart

Redhill Biopharma Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -75.99 -47.55 0.00 0.00 -3,379.51

Redhill Biopharma Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 334.57 -240.56 124.14 -123.05 122.26

STU:2RH vs LVRLF, BUDZ, GELS: FCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Redhill Biopharma's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Redhill Biopharma FCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Redhill Biopharma's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Redhill Biopharma's FCF Margin % falls into.


STU:2RH
18GF Score
Redhill Biopharma Ltd STU:2RH
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Redhill Biopharma FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Redhill Biopharma's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-8.246/0.244
=-3,379.51 %

Redhill Biopharma's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-3.96/-3.239
=122.26 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 122.26% mean?
Redhill Biopharma (STU:2RH) has a FCF Margin % of 122.26% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Redhill Biopharma and its competitors. According to the industry distribution chart, Redhill Biopharma ranks #943 out of 958 companies in the Drug Manufacturers industry, placing it in the top 98.4%.
Is Redhill Biopharma's FCF Margin % too high?
Redhill Biopharma's current FCF Margin % is 122.26%. The Drug Manufacturers industry median FCF Margin % is 2.51. Redhill Biopharma's value of 122.26% is 4770.9% above this industry median. Based on the distribution chart, Redhill Biopharma ranks #943 out of 958 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Redhill Biopharma has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Redhill Biopharma's FCF Margin % compare to LVRLF and BUDZ?
According to the Drug Manufacturers industry distribution chart, Redhill Biopharma ranks #943 out of 958 companies for FCF Margin %. This places Redhill Biopharma in the lower half of its industry. The industry median FCF Margin % is 2.51. Redhill Biopharma's value of 122.26% is 4770.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.51, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Redhill Biopharma's current FCF Margin % of 122.26% is 4770.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Redhill Biopharma and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Redhill Biopharma's current FCF Margin % is 122.26%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Redhill Biopharma stock overvalued right now?
Redhill Biopharma (STU:2RH) has a current FCF Margin % of 122.26%. The current FCF Margin % is 122.26% and 4770.9% above the Drug Manufacturers industry median of 2.51. Redhill Biopharma's overall GF Score™ is 18/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Redhill Biopharma (STU:2RH), the current FCF Margin % is 122.26% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Redhill Biopharma Business Description

Other Exchanges RDHL:USA
Address 21 Ha’arba’a Street, Tel Aviv, ISR, 6473921
RedHill Biopharma Ltd is a specialty biopharmaceutical company mainly focused on the U.S. development and commercialization of drugs for GI diseases, infectious diseases, and oncology. The Company is mainly focused on the advancement of its development pipeline of clinical-stage therapeutic candidates and also commercializes its GI-related product, Talicia (omeprazole, amoxicillin, and rifabutin) in the U.S. Its therapeutic candidates include opaganib, RHB-204, RHB-104, RHB-102 (Bekinda), and RHB-107.
18GF Score

Get the complete analysis for STU:2RH

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.24
Price